BIRC5, baculoviral IAP repeat containing 5, 332

N. diseases: 199; N. variants: 11
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0009375
Disease: Colonic Neoplasms
Colonic Neoplasms
0.340 Biomarker group CTD_human gamma-Secretase inhibitors abrogate oxaliplatin-induced activation of the Notch-1 signaling pathway in colon cancer cells resulting in enhanced chemosensitivity. 19147571 2009
CUI: C0009375
Disease: Colonic Neoplasms
Colonic Neoplasms
0.340 Therapeutic group CTD_human gamma-Secretase inhibitors abrogate oxaliplatin-induced activation of the Notch-1 signaling pathway in colon cancer cells resulting in enhanced chemosensitivity. 19147571 2009
CUI: C0009375
Disease: Colonic Neoplasms
Colonic Neoplasms
0.340 AlteredExpression group LHGDN Survivin and Cyclooxygenase-2 are co-expressed in human and mouse colon carcinoma and in terminally differentiated colonocytes. 17128412 2007
CUI: C0009375
Disease: Colonic Neoplasms
Colonic Neoplasms
0.340 GeneticVariation group LHGDN Gene therapy for colon cancer by adeno-associated viral vector-mediated transfer of survivin Cys84Ala mutant. 15685548 2005
CUI: C0009375
Disease: Colonic Neoplasms
Colonic Neoplasms
0.340 Therapeutic group CTD_human [Antisense RNA targeting survivin enhances the chemosensitivity of LOVO/Adr cells to taxotere]. 16224667 2005
CUI: C0009375
Disease: Colonic Neoplasms
Colonic Neoplasms
0.340 Biomarker group CTD_human [Antisense RNA targeting survivin enhances the chemosensitivity of LOVO/Adr cells to taxotere]. 16224667 2005
CUI: C0009375
Disease: Colonic Neoplasms
Colonic Neoplasms
0.340 AlteredExpression group LHGDN Expression of IAP family proteins in colon cancers from patients with different age groups. 15138717 2004
CUI: C0009375
Disease: Colonic Neoplasms
Colonic Neoplasms
0.340 AlteredExpression group LHGDN Survivin enhances Fas ligand expression via up-regulation of specificity protein 1-mediated gene transcription in colon cancer cells. 15004200 2004